Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.9%

2 terminated/withdrawn out of 68 trials

Success Rate

93.9%

+7.4% vs industry average

Late-Stage Pipeline

9%

6 trials in Phase 3/4

Results Transparency

0%

0 of 31 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
20(62.5%)
Phase 2
3(9.4%)
Phase 3
3(9.4%)
Phase 4
3(9.4%)
Phase 1
3(9.4%)
32Total
N/A(20)
Phase 2(3)
Phase 3(3)
Phase 4(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (68)

Showing 20 of 68 trials
NCT03671291Not ApplicableCompleted

Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV

Role: collaborator

NCT07485413Active Not Recruiting

Looking for VUS to Confirm Dominant Wolfram-like Syndrome Instead of Recessive Wolfram Syndrome

Role: lead

NCT07336966Not Yet Recruiting

Does Recessive Optic Atrophy Due to WFS1 Exist?

Role: lead

NCT07313085Not Yet Recruiting

Mechanisms of Fecal Incontinence in Wolfram Syndrome

Role: lead

NCT06934759Enrolling By Invitation

Impact and Lived Experience of Parents of a Child With a Large or Giant Congenital Melanocytic Nevus

Role: collaborator

NCT07305103Active Not Recruiting

Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning

Role: collaborator

NCT06585020Phase 2Recruiting

Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection

Role: collaborator

NCT06682819Not ApplicableRecruiting

Metabolomics Analysis According to the Retinal Nerve Fiber Layer in Patients With NOHL Mutations (MétabOCT)

Role: lead

NCT03272724Recruiting

French National Observatory on Infective Endocarditis

Role: collaborator

NCT05100823Not ApplicableTerminated

Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies

Role: collaborator

NCT05521568Completed

Diagnostic Accuracy of Rapid Molecular Tests for Group A Streptococcal Pharyngitis Using Saliva Samples

Role: collaborator

NCT05821478Phase 3Recruiting

Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients

Role: collaborator

NCT05048030Completed

Survey of Lifestyle and Its Feelings in Families of Patients in Home Parenteral Nutrition

Role: collaborator

NCT04712136Not ApplicableCompleted

Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations

Role: collaborator

NCT06892951Phase 1Not Yet Recruiting

CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia

Role: collaborator

NCT04859608Phase 3Completed

Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU)

Role: collaborator

NCT06831799Completed

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Role: collaborator

NCT04581278Completed

Validation Study of the Feasibility of an Integrated Diagnostic System of Anatomo-pathological Lesions - Including Rejections - Appearing in Renal Grafts in the First Year of Transplant for Applicability in Routine Clinical Practice : KTD Innov-2 Study

Role: collaborator

NCT05897879Not ApplicableRecruiting

Impact of Bacterial Expression and Immune Response in the Severity of Pertussis

Role: collaborator

NCT02965326Not ApplicableRecruiting

Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients

Role: lead